Ms. Linda Murakami
Director of Advocacy Relations
Amgen Oncology Division
Ms. Murakami serves as the Director of Advocacy Relations in Amgen Oncology Division. She manages a wide range of cancer advocacy programs, which help patients and reduce the impact of these cancers. Ms. Murakami works collaboratively with patient and patient advocacy organizations, like PHEN, to identify better ways to serve patients. Prostate is one area of focus involving educating the community and making them aware of the importance of early detection screening and the available treatment options, including clinical trials, for men diagnosed with prostate cancer. In addition to her work with Prostate cancer patients, she works to decrease the disparity gap in other cancer therapeutic areas.
Carmen White
Multicultural Participant Experience Lead
Pfizer's Global Product Development Division
Carmen White serves as the Multicultural Participant Experience Lead in Pfizer’s Global Product Development Division and has clinical trials patient engagement and healthcare communications experience serving the public sector, academia, and the pharmaceutical industry on both the specialized-service agency and sponsor side. In her role, Carmen leads educational and awareness programing and works to continuously improve the participant experience to enable diverse and inclusive participation in clinical trials through equitable access and practices. Over her career, she has supported clinical trials for various Sponsors in multiple therapeutic areas and developed protocol review, public awareness, and community outreach programs for a leading multi-center comprehensive cancer center. Carmen holds a B.A. in Psychology from Hampton University, and a Master of Business Administration in Marketing and resides in Jacksonville, Florida.
Justin Lorentz, MS
Genetic Counselor
Odette Cancer Center, Sunny Brook Health Center, Toronto, Canada
Neil Fleshner, MD, MPH, FRCSC
Chair, Division of Urology Professor, Department of Surgery
University of Toronto
Dr. Neil Fleshner is a surgeon and clinician scientist and an established leader in the field of cancer prevention. He holds the Martin Barkin Chair, Division of Urology at the University of Toronto and is a Professor in the Department of Surgery at the same University. Additionally, he is Staff in the Division of Urology at the University Health Network and Princess Margaret Hospital in Toronto, Canada and holds the Love Chair in Prostate Cancer Prevention at the Princess Margaret Hospital. He is also Head of Urology at Sunnybrook Health Sciences Centre. Dr. Fleshner earned his MPH degree from the School of Public Health at Columbia University and completed his oncology training at Memorial Sloan Kettering Cancer Center. He has achieved international reputation as a talented cancer researcher who has made significant contributions in the field of urologic oncology. His current research priorities include translational, clinical and health services research, focused primarily on understanding of prostate cancer pathogenesis, progression, and prevention. In addition to his clinical, academic and research commitments, he heads the University Health Network GU BioBank, a central data and specimen repository designed to support the use of biological fluids in disease discovery, prognostication and management. Dr Fleshner is an avid music lover and father of three. He has authored over 450 scientific papers and is a sought after speaker, both locally and internationally.